Correlation between Cerebral Vasospasm after Subarachnoid Hemorrhage and Intercellular Adhesion Molecule-1 Levels in Serum and Cerebrospinal Fluid

  • Cheong, Jin-Hwan (Department of Neurosurgery, Hanyang University Guri Hospital, Hanyang University College of Medicine) ;
  • Kim, Jae-Min (Department of Neurosurgery, Hanyang University Guri Hospital, Hanyang University College of Medicine) ;
  • Bak, Koang-Hum (Department of Neurosurgery, Hanyang University Guri Hospital, Hanyang University College of Medicine) ;
  • Kim, Choong-Hyun (Department of Neurosurgery, Hanyang University Guri Hospital, Hanyang University College of Medicine)
  • Published : 2005.07.28

Abstract

Objective : The purpose of this study is to evaluate the correlation of the ICAM-l levels in serum and CSF with cerebral vasospasm in early aneurysmal subarachnoid hemorrhage [SAH] patients. Methods : A prospective analysis was performed in thirty consecutive patients who underwent early surgery for intracranial aneurysmal SAH. The serum and CSF were obtained daily through the indwelling arterial lines and intraoperative ventriculostomy, or cisternal drain for 4 consecutive days after surgery. The ICAM-1 levels in serum and CSF samples were measured via quantitative enzyme-linked immunosorbent assay. Results : The mean concentration of serum in aneurysmal SAH patients was 207.89ng/ml compared with 132.25ng/ml in controls. The mean concentration of CSF in aneurysmal SAH patients was 76.39ng/ml compared with 3.96ng/ml in controls. There were no significant differences between serum and CSF ICAM-1 level with regards to clinical characteristics in patients with aneurysmal SAH [P>0.05]. However, CSF ICAM-1 levels increased significantly in patients with vasospasm compared with those without vasospasm [P<0.05]. Conclusion : The major result of this study shows that ICAM-1 is increased in CSF after early aneurysmal SAH and that this increase in ICAM-1 has correlation with cerebral vasospasm. Further study is needed to determine whether ICAM-1 levels may be indicator in the pathogenesis of important events leading to cerebral vasospasm.

Keywords

References

  1. Aihara Y, Kasuya H, Onda H, Hori T, Takeda J : Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 32 : 212-217, 2001 https://doi.org/10.1161/01.STR.32.1.212
  2. Bavbek M, Polin R, Kwan AL, Arthur AS, Kassel NF, Lee KS : Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 29 : 1930-1936, 1998 https://doi.org/10.1161/01.STR.29.9.1930
  3. Calderon TM, Sherman J, Wilkerson H, Hatcher VB, Berman JW : Interleukin-6 molecules c-sis gene expression in cultured human endothelial cells. Cell Immunol 143 : 118-126, 1992 https://doi.org/10.1016/0008-8749(92)90010-M
  4. Clark WM, Madden KP, Rothlein R, Zivin JA : Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 22 : 877-883, 1991 https://doi.org/10.1161/01.STR.22.7.877
  5. Connolly ES Jr, Winfree CJ, Springer TA, Naka Y, Liao H, Yan SD, et al : Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 97 : 209-216, 1996 https://doi.org/10.1172/JCI118392
  6. Cybulsky MI, Gimbrone MA Jr : Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251 : 788-791, 1991 https://doi.org/10.1126/science.1990440
  7. Diamond MS, Staunton DE, Marlin SD, Springer TA : Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulinlike domain of ICAM-1(CD54) and its regulation by glycosylation. Cell 65 : 961-971, 1991 https://doi.org/10.1016/0092-8674(91)90548-D
  8. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, et al : Cerebral vasospasm after subarachnoid hemorrhage : putative role of inflammation. Neurosurgery 53 : 123-135, 2003 https://doi.org/10.1227/01.NEU.0000068863.37133.9E
  9. Engler RL, Schmid-Schonbein GW, Pavelec RS : Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 111 : 98-111, 1983
  10. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, et al : Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 31 : 2971- 2975, 2000 https://doi.org/10.1161/01.STR.31.12.2971
  11. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, et al : Inflammatory cytokines in subarachnoid hemorrhage : association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychatry 70 : 534-537, 2001 https://doi.org/10.1136/jnnp.70.4.534
  12. Fisher CM, Kistler JP, Davis JM : Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6 : 1-9, 1980 https://doi.org/10.1227/00006123-198001000-00001
  13. Gaetani P, Tartara F, Pignatti, Tancioni F, Rodriguez Y, Baena RR, et al : Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 20 : 337-342, 1998 https://doi.org/10.1080/01616412.1998.11740528
  14. Gearing AJ, Newman W : Circulating adhesion molecules in disease. Immunol Today 14 : 506-512, 1993 https://doi.org/10.1016/0167-5699(93)90267-O
  15. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA : Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82 : 786-790, 1995 https://doi.org/10.3171/jns.1995.82.5.0786
  16. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM : A randomized, double-blind, vehecle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage : a cooperative study in North America. J Neurosurg 86 : 467-474, 1997 https://doi.org/10.3171/jns.1997.86.3.0467
  17. Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo KK, Thompson CB, et al : Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 17 : 246-253, 1986 https://doi.org/10.1161/01.STR.17.2.246
  18. Handa Y, Kubota T, Kaneko M, Tsuchida A, Kobayashi H, Kawano H, et al : Expression of intercellular adhesion molecule 1(ICAM-1) on the cerebral artery following subarachnoid hemorrhage in rats. Acta Neurochir(Wien) 132 : 92-97, 1995 https://doi.org/10.1007/BF01404854
  19. Hasan D, Tanghe J : Distribution of cisternal blood in patients with acute hydrocephalus after subarachnoid hemorrhage. Ann Neurol 31 : 374-378, 1992 https://doi.org/10.1002/ana.410310405
  20. Hunt WE, Hess RM : Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28 : 14-20, 1968 https://doi.org/10.3171/jns.1968.28.1.0014
  21. Jang SJ, Kang SD, Yun KJ : Systemic administration of the Potassium Channel Activator in the Polystylene Latex Beadinduced Cerebral Vasospasm. J Korean Neurosurg Soc 29 : 719-724, 2000
  22. Jennett B, Bond M : Assessment of outcome after severe brain damage : A practical scale. Lancet 1 : 480-484, 1975
  23. Kanse SM, Takahashi K, Lam HC, Rees A, Wareen JB, Porta M, et al : Cytokine stimulated endothelin release from endothelial cells. Life Sci 48 : 1379-1384, 1991 https://doi.org/10.1016/0024-3205(91)90434-D
  24. Kassell NF, Sasaki T, Colohan AR, Nazar G : Cerebral vasospasm following subarachnoid hemorrhage. Stroke 16 : 562-572, 1985 https://doi.org/10.1161/01.STR.16.4.562
  25. Kikuchi T, Okuda Y, Kaito N, Abe T : Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res 17 : 106-108, 1995 https://doi.org/10.1080/01616412.1995.11740296
  26. Kraus J, Oschmann P, Leis S, Neundorfer B, Heckmann JG : High concentration of sVCAM-1 and sICAM-1 in the cerebrospinal fluid of patients with intracerebral haemorrhage are associated with poor outcome. J Neurol Neurosurg Psychiatry 73 : 346-347, 2002 https://doi.org/10.1136/jnnp.73.3.346
  27. Lin CL, Lo YC, Chang CZ, Kwan AL, Chen IJ, Howng SL : Prevention of cerebral vasospasm by a capsaicin derivative, glyceryl nonivamide, in an experimental model of subarachnoid hemorrhage. Surg Neurol 55 : 297-301, 2001 https://doi.org/10.1016/S0090-3019(01)00438-4
  28. Lindsberg PJ, Carpen O, Paetau A, Karjalainen-Lindsberg ML, Kaste M : Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 94 : 939-945, 1996 https://doi.org/10.1161/01.CIR.94.5.939
  29. Ley K, Gaehtgens P : Endothelial, not hemodynamic, differences are responsible for preferential leukocyte rolling in rat mesenteric venules. Circ Res 69 : 1034-1041, 1991 https://doi.org/10.1161/01.RES.69.4.1034
  30. Macdonald RL, Weir B : Molecular biology and genetics, in Macdonald RL, Weir B (eds) : Cerebral vasospasm, San Diego, Academic Press, 2001, pp476-508
  31. Mack WJ, Mocco J, Hoh DJ, Huang J, Choudhri TF, Kreiter KT, et al : Outcome prediction with serum intercellular adhesion molecule- 1 levels after aneurysmal subarachnoid hemorrhage. J Neurosurg 96 : 71-75, 2002 https://doi.org/10.3171/jns.2002.96.1.0071
  32. Manno EM, Gress DR, Ogilvy CS, Stone CM, Zervas NT : The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages : a pilot study. Neurosurgery 40 : 289-293, 1997 https://doi.org/10.1097/00006123-199702000-00010
  33. Maruo N, Morita I, Ishizaki Y, Murota S : Inhibitory effects of interleukin-6 on prostaglandin 12 production in cultured bovine vascular endothelial cells. Arch Biochem Biophys 292 : 600-604, 1992 https://doi.org/10.1016/0003-9861(92)90037-W
  34. Matsuo Y, Onodera H, Shiga Y, Shozuhara H, Ninomiya M, Kihara T, et al : Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res 656 : 344-352, 1994 https://doi.org/10.1016/0006-8993(94)91478-8
  35. Mayberg MR, Batjer HH, Dancey RG Jr, Diringer M, Haley EC, Heros RC, et al : Guildelines for the management of aneurysmal subarachnoid hemorrhage : A statement for healthcare professional from a special writing group of the Stroke Council, American Heart Association. Stroke 25 : 2315-2328, 1994 https://doi.org/10.1161/01.STR.25.11.2315
  36. Mocco J, Choudhri TF, Mack WJ, Laufer I, Lee J, Kiss S, et al : Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis. Neurosurgery 48 : 718-722, 2001 https://doi.org/10.1097/00006123-200104000-00002
  37. Mocco J, Mack WJ, Kim GH, Lozier AP, Laufer I, Kreiter KT, et al : Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 97 : 537-541, 2002 https://doi.org/10.3171/jns.2002.97.3.0537
  38. Nissen JJ, Mantle D, Blackburn A, Barnes J, Wooldridge T, Gregson B, et al : The selectin superfamily : the role of selectin adhesion molecules in delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Suppl) 76 : 55-60, 2000
  39. Nissen JJ, Mantle D, Gregson B, Mendelow AD : Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage : the immunoglobulin and selectin superfamilies. J Neurol Neurosurg Psychiatry 71 : 329-333, 2001 https://doi.org/10.1136/jnnp.71.3.329
  40. Ogilvy CS, Carter BS : A proposed comprehensive grading system to predict outcome for surgical management of intracranial aneurysms. Neurosurgery 42 : 959-970, 1998 https://doi.org/10.1097/00006123-199805000-00001
  41. Okada T, Harada T, Bark DH, Mayberg MR : A rat femoral artery model for vasospasm. Neurosurgery 27 : 349-356, 1990 https://doi.org/10.1227/00006123-199009000-00002
  42. Oshiro EM, Hoffman PA, Dietsch GN, Watts MC, Pardoll DM, Tamargo RJ : Inhibition of experimental vasospasm with antiintercellular adhesion molecule-1 monoclonal antibody in rats. Stroke 28 : 2031-2038, 1997 https://doi.org/10.1161/01.STR.28.10.2031
  43. Peterson JW, Nishizawa S, Hackett JD, Bun T, Teramura A, Zervas NT : Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke 21 : 133-137, 1990 https://doi.org/10.1161/01.STR.21.1.133
  44. Pigott R, Dillon LP, Hemingway IH, Gearing AJ : Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 16;187 : 584-589, 1992
  45. Polin RS, Bavbek M, Shaffrey ME, Billups K, Bogaev CA, Kassell NF, et al : Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 89 : 559-567, 1998 https://doi.org/10.3171/jns.1998.89.4.0559
  46. Polverini PJ : Cellular adhesion molecules. Newly identified mediators of angiogenesis. Am J Pathol 148 : 1023-1029, 1996
  47. Ram Z, Sahar A, Hadani M : Vasospasm due to massive subarachnoid haemorrhage : a rat model. Acta Neurochir (Wien) 110 : 181- 184, 1991 https://doi.org/10.1007/BF01400688
  48. Rosen DS, Macdonald RL : Grading of subarachnoid hemorrhage : modification of the World Federation of Neurosurgical Societies scale on the basis of data for a large series of patients. Neurosurgery 54 : 566-576, 2004 https://doi.org/10.1227/01.NEU.0000108862.32404.A5
  49. Sakaguchi A, Dohrman GJ, Mojtahedi S : Experimental vasospasm : experiences with a canine model and failure of naloxone therapy. Surg Neurol 22 : 527-531, 1984 https://doi.org/10.1016/0090-3019(84)90317-3
  50. Sills AK Jr, Clatterbuck RE, Thompson RC, Cohen PL, Tamargo RJ : Endothelial cell expression of intercellular adhesion molecule- 1 in experimental posthemorrhagic vasospasm. Neurosurgery 41 : 453-461, 1997 https://doi.org/10.1097/00006123-199708000-00025
  51. Soriano SG, Cowan DB, Proctor MR, Scott RM : Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. Neurosurgery 50 : 544-549, 2002 https://doi.org/10.1097/00006123-200203000-00022
  52. Taylor CL, Yuan Z, Selman WR, Ratcheson RA, Rimm AA : Mortality rates, hospital length of stay, and the cost of treating subarachnoid hemorrhage in older patients : institutional and geographical differences. J Neurosurg 86 : 583-588, 1997 https://doi.org/10.3171/jns.1997.86.4.0583